Richard van Altena
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology 19
- Antimicrobial Resistance in Staphylococcus 7
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 12
- Respiratory Support and Mechanisms 8
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 16
-
- Pneumonia and Respiratory Infections 11
-
- Antibiotic Resistance in Bacteria 6
-
- Infectious Diseases and Tuberculosis 5
- Co-authors
- Dirkje S. PostmaJ KraanG H KoëterJan‐Willem C. AlffenaarTjip S. van der WerfPeter J. WijkstraJos G. W. KosterinkFernando Gimeno Marco
- Journals
- American Journal of Respiratory and Critical Care Medicine (2 papers)Clinical Infectious Diseases (1 paper)Spine (1 paper)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Richard van Altena
54 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 127
- Issues, ethics and legal aspects 66
- Infectious Diseases 958
- Pulmonary and Respiratory Medicine 1.3k
- Complementary and alternative medicine 219
- Pharmacology 419
Countries citing papers authored by Richard van Altena
This map shows the geographic impact of Richard van Altena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard van Altena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard van Altena more than expected).
Fields of papers citing papers by Richard van Altena
This network shows the impact of papers produced by Richard van Altena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard van Altena. The network helps show where Richard van Altena may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard van Altena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 20 | |
| 2 | 2015 | 27 | |
| 3 | 2015 | 44 | |
| 4 | 2014 | 69 | |
| 5 | 2014 | 61 | |
| 6 | 2013 | 46 | |
| 7 | 2013 | 50 | |
| 8 | 2012 | 111 | |
| 9 | 2011 | 25 | |
| 10 | 2011 | 51 | |
| 11 | 2010 | 28 | |
| 12 | 2010 | 39 | |
| 13 | 2009 | 28 | |
| 14 | 2009 | 77 | |
| 15 | 2006 | 10 | |
| 16 | 2004 | 85 | |
| 17 | 1997 | 134 | |
| 18 | 1997 | 1 | |
| 19 | 1996 | 74 | |
| 20 | 1992 | 1 |
About Richard van Altena
Richard van Altena is a scholar working on Molecular Medicine, Infectious Diseases and Pharmacology, having authored 54 papers that have together received 3.0k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (19 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Pneumonia and Respiratory Infections (11 papers), Respiratory Support and Mechanisms (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Infectious Diseases and Tuberculosis (5 papers). The work is most often cited by research in Issues, ethics and legal aspects (66 citations), Infectious Diseases (958 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Richard van Altena has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Dirkje S. Postma, J Kraan, G H Koëter, Jan‐Willem C. Alffenaar, Tjip S. van der Werf, Peter J. Wijkstra, G H Koëter, Jos G. W. Kosterink, Fernando Gimeno Marco and DS Postma. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Spine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.